lm 24056 has been researched along with Duodenal Ulcer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, EJ; Wormsley, KG | 1 |
| Boyd, EJ; Wilson, JA; Wormsley, KG | 1 |
1 trial(s) available for lm 24056 and Duodenal Ulcer
| Article | Year |
|---|---|
Inhibition of pentagastrin-stimulated and overnight gastric secretion by LM24056, a new phenothiazine-derived antisecretory drug.
Topics: Anti-Ulcer Agents; Duodenal Ulcer; Gastric Juice; Humans; Pentagastrin; Pepsin A; Phenothiazines; Random Allocation; Secretory Rate | 1981 |
1 other study(ies) available for lm 24056 and Duodenal Ulcer
| Article | Year |
|---|---|
Effects of some polycyclic drugs on gastric secretion and on the healing of duodenal ulcers.
Topics: Anti-Ulcer Agents; Calcium; Dibenzazepines; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Mianserin; Pentagastrin; Pepsin A; Phenothiazines; Trimipramine | 1985 |